/R E P E A T -- New Wave: To Provide Sponsorship for the Documentary "The World on Drugs"/
New Wave Holdings Corp. (OTC: TRMND) announced its sponsorship of the upcoming documentary "The World on Drugs," addressing drug policy, psychedelic medicine, and mental health issues. The film aims to reshape public perception regarding psychedelics amid the pandemic and mental health crises. Following initial filming in Mexico, the next phase will focus on Vancouver, featuring insights from mental health experts. New Wave is committed to supporting research and creating solutions in the psychedelic sector, highlighting its corporate social responsibility during challenging times.
- Sponsoring a documentary addressing crucial public health issues, potentially enhancing brand visibility.
- Focus on emerging research in psychedelic medicine, positioning the company well in the growing market for mental health treatments.
- Investment in documentary may not yield immediate financial returns.
- Potential risks associated with regulatory changes affecting the psychedelic sector.
TORONTO, Oct. 13, 2020 /PRNewswire/ - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (FWB: 0XM2) (OTC: TRMND) an investment issuer that provides capital and support services, announced it will provide sponsorship for the next phase of the upcoming Microdose Psychedelic Insights documentary "The World on Drugs", a Bold Commentary On Drug Policy, Psychedelic Medicine & Mental Health.
At this critical intersection of the pandemic, the opioid crisis and the mental health epidemic, the team at New Wave Holdings is proud to sponsor this international effort to shift policy and public opinion surrounding these major public health concerns. The project is aimed at reframing the context of psychedelic medicines and illuminating the radical hope they offer to humankind during this critical juncture of disruption and evolution.
With exclusive content filmed by the Microdose team in Mexico in the first phase of this project, New Wave Holdings is pleased to announce funding for the film to carry this message in the next step of its journey in Vancouver, British Columbia. As new research emerges to reinforce the idea that psychedelic compounds are poised to revolutionize mental healthcare, so are the powerful and compelling stories of the people who have healed from them. With powerful commentary from prominent voices across Mexico, the next step in production of "The World on Drugs" aims to speak with leading experts in Vancouver - another highly relevant location to this discussion.
The team at New Wave Holdings believes in providing robust mental health treatments to the world and that psychedelics hold immense promise for humanity through this crucial moment in our history. They are proud to support the novel efforts by the Microdose team to explore psychedelics and mental health across borders and through a rich, diverse lens. "The World on Drugs" is meant to not simply just inform, but to inspire actionable change and tangible impact. The team at New Wave Holdings is proud to play a direct role in this necessary effort and feels it to be their corporate social responsibility during these trying times.
ABOUT NEW WAVE HOLDINGS CORP.
New Wave Holdings Corp. (CSE: SPOR, FWB: 0XM2, OTC:TRMND) is an investment issuer focused on the burgeoning psychedelic and esports sectors. In the psychedelic sector, New Wave will focus on supporting research on active psychedelic compounds, creation of consumer products based on functional mushrooms, and developing an IP portfolio focusing on psilocybin, LSD, MDMA, and ketamine derived treatments for neuropsychiatric diseases.
Investors interested in connecting with New Wave Holdings can learn more about the company and contact the team at http://newwavecorp.com
ABOUT MICRODOSE PSYCHEDELIC INSIGHTS
Microdose Psychedelic Insights aims to unlock the potential of psychedelics through Industry events, market intelligence, original, evidence-based content, strategy and community. They enable and empower society at large to make better, more mindful decisions about psychedelics and its intersection with healthcare, medicine and personal growth. Microdose work with the industry's most influential stakeholders, some of the world's best-known brands and an unrivalled network of scientists, researchers, analysts, innovators, investors and advisors.
To request media accreditation, or to arrange interviews with key personnel please contact:
Kristina Spionjak / kristina@microdose.buzz / https://microdose.buzz
Information relating Microdose Psychedelic Insight contained in this news release was provided by Microdose Psychedelic Insight and/or its agent and has not been independently verified by the Company. The Company does not take responsibility for the accuracy of such information.
The CSE has not in any way passed on the merits of the Acquisition, and neither has approved nor disapproved the contents of this press release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
FORWARD-LOOKING INFORMATION DISCLAIMER
Certain statements contained in this news release may constitute forward–looking information, including but not limited to, applicable regulatory approval in connection with the Acquisition, the closing of the Acquisition, expansion of operations, size and quality of future tournaments and projections regarding attendance at future events. Forward–looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward–looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward–looking information. The Company's actual results could differ materially from those anticipated in this forward–looking information as a result of competitive factors and competition for investment opportunities, challenges relating to operations in international markets, transaction execution risk, changes to the Company's strategic growth plans, and other factors, many of which are beyond the control of the Company. The Company believes that the expectations reflected in the forward–looking information are reasonable based on current expectations and potential investment pipeline, but no assurance can be given that these expectations will prove to be correct and such forward–looking information should not be unduly relied upon. Any forward–looking information contained in this news release represents the Company's expectations as of the date hereof and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward–looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
View original content to download multimedia:http://www.prnewswire.com/news-releases/r-e-p-e-a-t----new-wave-to-provide-sponsorship-for-the-documentary-the-world-on-drugs-301150480.html
SOURCE New Wave Holdings Corp.
FAQ
What is New Wave Holdings Corp. sponsoring?
What is the focus of the documentary "The World on Drugs"?
What is the stock symbol for New Wave Holdings Corp.?
Where is the next phase of the documentary filming taking place?
